sabarubicin has been researched along with etoposide in 2 studies
Studies (sabarubicin) | Trials (sabarubicin) | Recent Studies (post-2010) (sabarubicin) | Studies (etoposide) | Trials (etoposide) | Recent Studies (post-2010) (etoposide) |
---|---|---|---|---|---|
29 | 5 | 4 | 18,306 | 3,693 | 4,900 |
Protein | Taxonomy | sabarubicin (IC50) | etoposide (IC50) |
---|---|---|---|
nuclear receptor coactivator 1 isoform 1 [Homo sapiens] | Homo sapiens (human) | 1.153 | |
nuclear receptor coactivator 3 isoform a | Homo sapiens (human) | 1.4284 | |
Polyunsaturated fatty acid lipoxygenase ALOX15 | Oryctolagus cuniculus (rabbit) | 3.187 | |
Caspase-3 | Homo sapiens (human) | 1 | |
DNA topoisomerase 2-beta | Homo sapiens (human) | 0.4299 | |
Solute carrier organic anion transporter family member 1B3 | Homo sapiens (human) | 4.18 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Binaschi, M; Camarda, G; Goso, C; Maggi, CA; Manzini, S; Salvatore, C | 1 |
2 other study(ies) available for sabarubicin and etoposide
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
NF-kappaB activation contributes to anthracycline resistance pathway in human ovarian carcinoma cell line A2780.
Topics: Anthracyclines; Antineoplastic Agents, Phytogenic; Blotting, Western; Cell Line, Tumor; Cell Survival; Disaccharides; DNA Topoisomerases, Type I; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Neoplasm; Enzyme Activation; Etoposide; Female; Gene Expression; Humans; Multidrug Resistance-Associated Proteins; NF-kappa B; Nitriles; Ovarian Neoplasms; RNA, Messenger; Signal Transduction; Sulfones; Time Factors; Vinblastine | 2005 |